no disputing the directors have some serious skin in the game on this one. last rights issue they dipped into their coffers for almost $1,200,000 (see last weeks announcement) the rights issue was only for $2,800,000 so a serious show of support. as Maxcha pointed out, it wouldn't have been a good look if they agreed to put underwriting funds in by 9th March and in the meantime had an announcement that made the shareprice go bunta. i.e they are contributing funds at 2c when the shareprice is up around 4cps or 5cps. a few other good points have also been raised, there is no longer the going concern here that the auditors raised, due to the increase in cash reserves. from discussions with directors that a few people have had, they have entire confidence the 4cps ALTO options will be in the money by September, so possibly another $4,000,000 coming in then.
A) directors personally support around 30% of rights issue B) should no longer be a going concern (at best this was just a formality by auditor who likely disregarded options) C) now rights issue finalized, clears the air for pending announcements D) 1, possibly 2 hospital trial updates on the way E) update on major international interest that they hinted at late last year
remember folks wise owl target of 7.2c and the australian voting it the #1 investment for 2012. lets live up to the expectations now
ALT Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held